306 results
8-K
r73hs ulmcut
26 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
EX-99.1
lrf wm6qhq0vy47g
25 Mar 24
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
9:55pm
8-K
45s3tan5x91l8x43hp1
21 Mar 24
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
7:15am
8-K
EX-99.1
klztvu8 fjl
21 Mar 24
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
7:15am
8-K
EX-99.1
xfn1pmk38
14 Feb 24
Results of Operations and Financial Condition
5:16pm
8-K/A
in3k3zktybeur
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K/A
EX-99.1
us5z4djz
12 Jan 24
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-99.1
6ty2w7
14 Nov 23
Regulation FD Disclosure
12:00am
8-K
ktyk4z1e1 0tb3q
2 Nov 23
Changes in Registrant's Certifying Accountant
5:00pm
424B3
ksmo5
1 Nov 23
Prospectus supplement
5:18pm
8-K
EX-14.1
wyws1bj3i2
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
mgy 34609lg3
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
424B3
4x7re97k ycn
27 Oct 23
Prospectus supplement
5:10pm